IKS Healthcare pursues major acquisition of TruBridge for $600 million. The Jhunjhunwala-backed healthcare technology company is in advanced negotiations to acquire the Nasdaq-listed US firm, marking its largest purchase to date. The deal would strengthen IKS's position in healthcare solutions and revenue cycle management. IKS is securing $675 million in financing from Citi, Deutsche Bank, and JP Morgan to fund the all-cash offer and refinance TruBridge's debt. The acquisition reflects strong consolidation momentum in the healthcare technology sector. IKS, which delivered a 530-fold return during its December 2024 listing, continues aggressive expansion in US healthcare markets. A formal announcement is expected shortly as negotiations advance.
Post from MarketNews_en
Log in to interact with content.